MOH vs TEM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MOH · Molina Healthcare$208.99 ▼ 3.53%
TEM · Tempus AI$76.05 ▲ 7.98%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MOH +48.3%
- TEM +5.9%
Head to head
| Metric | MOH | TEM |
|---|---|---|
| Price | $208.99 | $76.05 |
| Change today | ▼ 3.53% | ▲ 7.98% |
| Market cap | $10.91B | $13.87B |
| Return, 3 months | +5.1% | +38.1% |
| Return, year to date | +20.4% | +28.8% |
| Return, 1 year | +37.4% | +6.3% |
| P/E (TTM) | – | – |
| P/B | 2.6 | 27.7 |
| P/E percentile vs own 5y | 0th | 6th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -3.4% | +21.6% |
| Net profit growth (YoY) | -51.9% | +113.2% |
| Gross margin | 8.0% | 64.0% |
| Operating margin | 0.6% | -19.8% |
| Net margin | -0.1% | -17.8% |
| Return on equity | -1.2% | -67.4% |
| Analyst target vs. price | +9.1% | +15.5% |
| Analyst buy share | 29% | 62% |
| RSI (14) | 52 | 54 |
| 30-day volatility | 46.0% | 88.7% |
| Max drawdown, 1 year | -39.2% | -54.6% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TEM is the largest of the group by market value.
- MOH has returned the most over the past year.
- TEM is growing revenue fastest.
- MOH keeps the most profit per dollar of sales.
- MOH has been the calmest stock over the last 30 days.